Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Mammaplasty | 168 | 2024 | 1204 | 20.810 |
Why?
|
Patient Satisfaction | 132 | 2023 | 3391 | 12.140 |
Why?
|
Mastectomy | 115 | 2024 | 1793 | 9.450 |
Why?
|
Quality of Life | 161 | 2024 | 12788 | 7.660 |
Why?
|
Breast Implants | 53 | 2023 | 387 | 6.930 |
Why?
|
Breast Neoplasms | 148 | 2024 | 20827 | 5.530 |
Why?
|
Breast Implantation | 31 | 2023 | 218 | 5.260 |
Why?
|
Psychometrics | 61 | 2024 | 3000 | 4.800 |
Why?
|
Esthetics | 28 | 2023 | 305 | 4.360 |
Why?
|
Surgery, Plastic | 24 | 2023 | 624 | 4.140 |
Why?
|
Cosmetic Techniques | 12 | 2016 | 135 | 3.880 |
Why?
|
Surgical Flaps | 56 | 2021 | 1629 | 3.330 |
Why?
|
Rhytidoplasty | 8 | 2016 | 60 | 2.720 |
Why?
|
Nipples | 18 | 2023 | 219 | 2.470 |
Why?
|
Skin Aging | 5 | 2016 | 127 | 1.840 |
Why?
|
Lymphedema | 9 | 2023 | 534 | 1.820 |
Why?
|
Tissue Expansion Devices | 18 | 2022 | 156 | 1.770 |
Why?
|
Mastectomy, Segmental | 17 | 2023 | 956 | 1.730 |
Why?
|
Cicatrix | 6 | 2021 | 763 | 1.680 |
Why?
|
Postoperative Complications | 60 | 2024 | 15281 | 1.560 |
Why?
|
Weight Loss | 11 | 2023 | 2625 | 1.490 |
Why?
|
Bariatric Surgery | 11 | 2023 | 952 | 1.470 |
Why?
|
Self Report | 15 | 2020 | 3550 | 1.410 |
Why?
|
Face | 14 | 2021 | 993 | 1.370 |
Why?
|
Female | 284 | 2024 | 380020 | 1.330 |
Why?
|
Rejuvenation | 5 | 2014 | 91 | 1.260 |
Why?
|
Body Image | 14 | 2021 | 610 | 1.240 |
Why?
|
Humans | 386 | 2024 | 743811 | 1.220 |
Why?
|
Tissue Expansion | 14 | 2020 | 162 | 1.200 |
Why?
|
Monitoring, Ambulatory | 2 | 2021 | 358 | 1.170 |
Why?
|
Ambulatory Surgical Procedures | 3 | 2022 | 455 | 1.160 |
Why?
|
Reproducibility of Results | 39 | 2024 | 19894 | 1.150 |
Why?
|
Canada | 16 | 2024 | 2064 | 1.120 |
Why?
|
Breast | 13 | 2023 | 1970 | 1.100 |
Why?
|
Middle Aged | 175 | 2023 | 213241 | 1.050 |
Why?
|
Adult | 165 | 2024 | 213889 | 1.000 |
Why?
|
Patient Education as Topic | 11 | 2018 | 2278 | 0.990 |
Why?
|
Qualitative Research | 23 | 2023 | 2682 | 0.950 |
Why?
|
Mastectomy, Subcutaneous | 5 | 2018 | 46 | 0.940 |
Why?
|
Facial Neoplasms | 3 | 2021 | 121 | 0.940 |
Why?
|
Evidence-Based Medicine | 12 | 2019 | 3608 | 0.940 |
Why?
|
Wounds and Injuries | 4 | 2020 | 2401 | 0.850 |
Why?
|
Cleft Lip | 8 | 2023 | 478 | 0.810 |
Why?
|
Obesity, Morbid | 6 | 2022 | 1213 | 0.810 |
Why?
|
Carcinoma, Basal Cell | 3 | 2018 | 545 | 0.800 |
Why?
|
Cleft Palate | 8 | 2023 | 560 | 0.790 |
Why?
|
Personal Satisfaction | 7 | 2022 | 641 | 0.770 |
Why?
|
Aged | 112 | 2023 | 163178 | 0.770 |
Why?
|
Facial Nerve Diseases | 1 | 2021 | 50 | 0.770 |
Why?
|
Quality Improvement | 8 | 2022 | 3750 | 0.760 |
Why?
|
Rhinoplasty | 4 | 2021 | 226 | 0.750 |
Why?
|
Skin Neoplasms | 10 | 2022 | 5691 | 0.740 |
Why?
|
Rectus Abdominis | 12 | 2020 | 97 | 0.730 |
Why?
|
Mohs Surgery | 3 | 2021 | 197 | 0.730 |
Why?
|
Sexuality | 3 | 2018 | 172 | 0.730 |
Why?
|
Facial Paralysis | 4 | 2021 | 338 | 0.710 |
Why?
|
Prospective Studies | 61 | 2023 | 53250 | 0.700 |
Why?
|
Self Concept | 5 | 2018 | 1024 | 0.700 |
Why?
|
Young Adult | 60 | 2022 | 56392 | 0.700 |
Why?
|
Treatment Outcome | 77 | 2022 | 63042 | 0.690 |
Why?
|
Internationality | 3 | 2020 | 1002 | 0.680 |
Why?
|
Leg Injuries | 4 | 2022 | 178 | 0.680 |
Why?
|
Pressure Ulcer | 2 | 2020 | 155 | 0.680 |
Why?
|
Thoracic Surgical Procedures | 2 | 2023 | 342 | 0.660 |
Why?
|
Surgical Procedures, Operative | 5 | 2022 | 1877 | 0.650 |
Why?
|
Arm | 1 | 2021 | 588 | 0.630 |
Why?
|
Fatigue | 3 | 2021 | 1530 | 0.630 |
Why?
|
Checklist | 7 | 2022 | 832 | 0.620 |
Why?
|
Follow-Up Studies | 48 | 2021 | 39001 | 0.610 |
Why?
|
Insurance, Health, Reimbursement | 2 | 2018 | 397 | 0.570 |
Why?
|
Blepharoplasty | 1 | 2017 | 50 | 0.570 |
Why?
|
Neoplasms | 11 | 2023 | 21675 | 0.550 |
Why?
|
Silicone Gels | 2 | 2013 | 39 | 0.540 |
Why?
|
Microsurgery | 14 | 2019 | 785 | 0.530 |
Why?
|
Adaptation, Psychological | 7 | 2022 | 2575 | 0.530 |
Why?
|
Aged, 80 and over | 44 | 2021 | 57744 | 0.530 |
Why?
|
Acne Vulgaris | 2 | 2019 | 302 | 0.530 |
Why?
|
Reoperation | 12 | 2024 | 4200 | 0.520 |
Why?
|
Decision Making | 11 | 2020 | 3887 | 0.500 |
Why?
|
General Surgery | 4 | 2023 | 1636 | 0.500 |
Why?
|
Sensation | 3 | 2022 | 336 | 0.500 |
Why?
|
Transplantation, Autologous | 13 | 2022 | 2123 | 0.500 |
Why?
|
Radiotherapy, Adjuvant | 12 | 2021 | 1770 | 0.480 |
Why?
|
Registries | 13 | 2023 | 8090 | 0.480 |
Why?
|
Quality of Health Care | 5 | 2022 | 4370 | 0.480 |
Why?
|
Silicones | 3 | 2016 | 250 | 0.460 |
Why?
|
Randomized Controlled Trials as Topic | 12 | 2019 | 9944 | 0.460 |
Why?
|
Preoperative Period | 3 | 2021 | 550 | 0.450 |
Why?
|
Carcinoma, Intraductal, Noninfiltrating | 9 | 2020 | 948 | 0.450 |
Why?
|
Hormone Replacement Therapy | 1 | 2018 | 708 | 0.450 |
Why?
|
Health Status | 8 | 2023 | 4031 | 0.450 |
Why?
|
Thoracic Wall | 4 | 2013 | 203 | 0.440 |
Why?
|
Adolescent | 48 | 2024 | 85729 | 0.440 |
Why?
|
Biomedical Research | 4 | 2016 | 3308 | 0.440 |
Why?
|
Skin | 3 | 2020 | 4372 | 0.430 |
Why?
|
Burns | 4 | 2021 | 1815 | 0.430 |
Why?
|
Male | 81 | 2023 | 349776 | 0.420 |
Why?
|
Sodium Chloride | 3 | 2016 | 625 | 0.420 |
Why?
|
Craniofacial Abnormalities | 4 | 2021 | 315 | 0.420 |
Why?
|
Carcinoma, Lobular | 2 | 2020 | 484 | 0.420 |
Why?
|
Interviews as Topic | 9 | 2019 | 2538 | 0.410 |
Why?
|
Religion and Medicine | 1 | 2013 | 163 | 0.390 |
Why?
|
Muscle Weakness | 2 | 2013 | 413 | 0.390 |
Why?
|
Motivation | 4 | 2021 | 1971 | 0.390 |
Why?
|
Time Factors | 36 | 2020 | 40038 | 0.390 |
Why?
|
United States | 42 | 2023 | 69859 | 0.390 |
Why?
|
Skin Care | 1 | 2011 | 49 | 0.380 |
Why?
|
Obesity | 8 | 2022 | 12744 | 0.380 |
Why?
|
Head and Neck Neoplasms | 8 | 2018 | 2736 | 0.380 |
Why?
|
Pain, Postoperative | 7 | 2021 | 1642 | 0.370 |
Why?
|
Journalism, Medical | 1 | 2010 | 73 | 0.360 |
Why?
|
Cross-Sectional Studies | 21 | 2023 | 25032 | 0.360 |
Why?
|
Tissue and Organ Harvesting | 3 | 2009 | 369 | 0.350 |
Why?
|
Lymphoma, Large-Cell, Anaplastic | 3 | 2020 | 169 | 0.350 |
Why?
|
Consensus | 7 | 2024 | 2954 | 0.340 |
Why?
|
Upper Extremity | 4 | 2023 | 647 | 0.330 |
Why?
|
Health Status Indicators | 3 | 2020 | 970 | 0.320 |
Why?
|
Gynecomastia | 2 | 2019 | 87 | 0.320 |
Why?
|
Free Tissue Flaps | 4 | 2019 | 328 | 0.320 |
Why?
|
Retrospective Studies | 51 | 2024 | 77410 | 0.320 |
Why?
|
Risk Assessment | 20 | 2020 | 23327 | 0.320 |
Why?
|
Chronic Disease | 2 | 2020 | 9139 | 0.320 |
Why?
|
Patients | 5 | 2023 | 899 | 0.300 |
Why?
|
Health Care Reform | 1 | 2017 | 1261 | 0.300 |
Why?
|
Weight Gain | 1 | 2017 | 2294 | 0.300 |
Why?
|
Neoplasms, Second Primary | 1 | 2015 | 1063 | 0.300 |
Why?
|
Lip | 2 | 2021 | 195 | 0.300 |
Why?
|
Choice Behavior | 1 | 2013 | 802 | 0.290 |
Why?
|
Patient Selection | 8 | 2021 | 4210 | 0.290 |
Why?
|
Patient-Centered Care | 4 | 2022 | 1438 | 0.290 |
Why?
|
Survivors | 3 | 2016 | 2291 | 0.290 |
Why?
|
Surgical Wound Infection | 5 | 2021 | 1539 | 0.290 |
Why?
|
Physician-Patient Relations | 5 | 2020 | 3229 | 0.280 |
Why?
|
Skin Transplantation | 2 | 2015 | 1074 | 0.280 |
Why?
|
Bandages | 2 | 2021 | 266 | 0.280 |
Why?
|
Venous Thrombosis | 5 | 2016 | 1240 | 0.270 |
Why?
|
Limb Salvage | 4 | 2022 | 433 | 0.270 |
Why?
|
Internship and Residency | 3 | 2023 | 5787 | 0.270 |
Why?
|
Research Design | 11 | 2022 | 5983 | 0.270 |
Why?
|
Carcinoma | 1 | 2017 | 2375 | 0.260 |
Why?
|
Societies, Medical | 4 | 2021 | 3740 | 0.250 |
Why?
|
Attitude to Health | 2 | 2018 | 2052 | 0.250 |
Why?
|
Practice Guidelines as Topic | 2 | 2020 | 7270 | 0.250 |
Why?
|
Health Services Research | 1 | 2012 | 1836 | 0.250 |
Why?
|
Aging | 2 | 2014 | 8655 | 0.250 |
Why?
|
Needs Assessment | 2 | 2012 | 1146 | 0.250 |
Why?
|
Ontario | 2 | 2023 | 383 | 0.250 |
Why?
|
Disclosure | 1 | 2010 | 737 | 0.250 |
Why?
|
Postoperative Care | 8 | 2019 | 1485 | 0.250 |
Why?
|
Physicians, Women | 2 | 2021 | 486 | 0.250 |
Why?
|
Specialties, Surgical | 2 | 2022 | 391 | 0.240 |
Why?
|
Delphi Technique | 3 | 2023 | 777 | 0.240 |
Why?
|
Hospitals | 7 | 2023 | 3953 | 0.240 |
Why?
|
Patient Preference | 3 | 2020 | 889 | 0.240 |
Why?
|
Breast Diseases | 1 | 2007 | 443 | 0.240 |
Why?
|
Publishing | 4 | 2021 | 833 | 0.240 |
Why?
|
Vagina | 2 | 2006 | 825 | 0.230 |
Why?
|
Scalp | 1 | 2006 | 378 | 0.230 |
Why?
|
Netherlands | 4 | 2021 | 2170 | 0.230 |
Why?
|
Lower Extremity | 4 | 2022 | 1158 | 0.230 |
Why?
|
Carcinoma, Squamous Cell | 5 | 2015 | 4033 | 0.230 |
Why?
|
Australia | 6 | 2023 | 1167 | 0.220 |
Why?
|
Logistic Models | 13 | 2017 | 13404 | 0.220 |
Why?
|
Implant Capsular Contracture | 2 | 2021 | 22 | 0.220 |
Why?
|
Postoperative Period | 4 | 2018 | 1841 | 0.220 |
Why?
|
Ear | 2 | 2021 | 172 | 0.220 |
Why?
|
Anxiety | 6 | 2021 | 4288 | 0.220 |
Why?
|
Mandibular Neoplasms | 2 | 2009 | 129 | 0.220 |
Why?
|
Mental Health | 1 | 2017 | 3012 | 0.220 |
Why?
|
Feasibility Studies | 4 | 2022 | 5078 | 0.220 |
Why?
|
Bariatrics | 1 | 2023 | 34 | 0.220 |
Why?
|
Prosthesis Design | 3 | 2017 | 2103 | 0.220 |
Why?
|
Faculty, Medical | 2 | 2021 | 1181 | 0.210 |
Why?
|
Prognosis | 15 | 2021 | 29052 | 0.210 |
Why?
|
Graft Survival | 7 | 2019 | 3734 | 0.210 |
Why?
|
Lymph Node Excision | 3 | 2023 | 1262 | 0.210 |
Why?
|
Stress, Psychological | 2 | 2019 | 4245 | 0.210 |
Why?
|
Muscle, Skeletal | 5 | 2012 | 4925 | 0.200 |
Why?
|
Hyperparathyroidism, Primary | 1 | 2024 | 160 | 0.200 |
Why?
|
Healthcare Disparities | 2 | 2016 | 3155 | 0.200 |
Why?
|
Cellulitis | 2 | 2021 | 206 | 0.200 |
Why?
|
Sunburn | 1 | 2022 | 155 | 0.190 |
Why?
|
Analysis of Variance | 4 | 2016 | 6356 | 0.190 |
Why?
|
Enoxaparin | 3 | 2012 | 377 | 0.190 |
Why?
|
Physician Executives | 1 | 2021 | 128 | 0.190 |
Why?
|
Contracture | 2 | 2022 | 223 | 0.190 |
Why?
|
Epigastric Arteries | 3 | 2018 | 96 | 0.190 |
Why?
|
Reference Values | 3 | 2023 | 4974 | 0.190 |
Why?
|
Periodicals as Topic | 1 | 2012 | 1429 | 0.190 |
Why?
|
Sex Reassignment Surgery | 1 | 2023 | 130 | 0.190 |
Why?
|
Clinical Trials, Phase I as Topic | 2 | 2020 | 323 | 0.190 |
Why?
|
Genitalia, Female | 1 | 2021 | 146 | 0.190 |
Why?
|
Neoplasm Recurrence, Local | 10 | 2019 | 9239 | 0.180 |
Why?
|
Quality Indicators, Health Care | 2 | 2023 | 1831 | 0.180 |
Why?
|
Delivery of Health Care | 2 | 2023 | 5319 | 0.180 |
Why?
|
New York City | 4 | 2016 | 705 | 0.180 |
Why?
|
Orthognathic Surgical Procedures | 1 | 2021 | 115 | 0.170 |
Why?
|
Risk Adjustment | 2 | 2020 | 594 | 0.170 |
Why?
|
Linear Models | 5 | 2018 | 5952 | 0.170 |
Why?
|
Ear Diseases | 1 | 2021 | 170 | 0.170 |
Why?
|
Age Factors | 10 | 2017 | 18355 | 0.170 |
Why?
|
Telemedicine | 3 | 2022 | 2874 | 0.170 |
Why?
|
Hand | 2 | 2019 | 884 | 0.170 |
Why?
|
Prosthesis Failure | 2 | 2019 | 1203 | 0.170 |
Why?
|
Group Practice | 1 | 2020 | 149 | 0.170 |
Why?
|
Striae Distensae | 1 | 2018 | 7 | 0.170 |
Why?
|
Child | 26 | 2021 | 77637 | 0.170 |
Why?
|
Thorax | 2 | 2019 | 547 | 0.170 |
Why?
|
Health Priorities | 1 | 2022 | 380 | 0.160 |
Why?
|
Dermatology | 4 | 2012 | 872 | 0.160 |
Why?
|
Personnel Selection | 1 | 2020 | 190 | 0.160 |
Why?
|
Surgical Mesh | 1 | 2021 | 276 | 0.160 |
Why?
|
Cross-Cultural Comparison | 2 | 2019 | 651 | 0.160 |
Why?
|
Sex Reassignment Procedures | 1 | 2018 | 49 | 0.160 |
Why?
|
Decision Trees | 3 | 2016 | 506 | 0.160 |
Why?
|
Capital Financing | 1 | 2018 | 58 | 0.160 |
Why?
|
Venous Thromboembolism | 4 | 2012 | 1670 | 0.160 |
Why?
|
Multivariate Analysis | 7 | 2013 | 12243 | 0.160 |
Why?
|
Odds Ratio | 4 | 2023 | 9848 | 0.150 |
Why?
|
Soft Tissue Neoplasms | 4 | 2008 | 1363 | 0.150 |
Why?
|
Ambulatory Care Facilities | 2 | 2021 | 934 | 0.150 |
Why?
|
Denmark | 1 | 2020 | 738 | 0.150 |
Why?
|
Gynecologic Surgical Procedures | 1 | 2021 | 337 | 0.150 |
Why?
|
Leadership | 3 | 2021 | 1357 | 0.150 |
Why?
|
Research Subjects | 1 | 2019 | 239 | 0.150 |
Why?
|
Neoplasm Invasiveness | 5 | 2019 | 3617 | 0.150 |
Why?
|
Anticoagulants | 6 | 2012 | 4599 | 0.150 |
Why?
|
Dermatologic Agents | 2 | 2011 | 278 | 0.150 |
Why?
|
Health Facilities | 1 | 2022 | 572 | 0.150 |
Why?
|
Databases, Factual | 8 | 2019 | 7729 | 0.140 |
Why?
|
Incidence | 13 | 2020 | 20948 | 0.140 |
Why?
|
Benchmarking | 3 | 2019 | 1042 | 0.140 |
Why?
|
Combined Modality Therapy | 9 | 2014 | 8637 | 0.140 |
Why?
|
Mastectomy, Modified Radical | 2 | 2010 | 62 | 0.140 |
Why?
|
Neoadjuvant Therapy | 4 | 2021 | 2727 | 0.140 |
Why?
|
Genes, BRCA2 | 2 | 2020 | 618 | 0.140 |
Why?
|
Physical Therapy Modalities | 4 | 2013 | 549 | 0.140 |
Why?
|
Arabidopsis Proteins | 1 | 2018 | 259 | 0.140 |
Why?
|
Ultraviolet Rays | 1 | 2021 | 1060 | 0.130 |
Why?
|
Mastectomy, Radical | 1 | 2015 | 20 | 0.130 |
Why?
|
Genes, BRCA1 | 2 | 2020 | 781 | 0.130 |
Why?
|
Pilot Projects | 6 | 2024 | 8316 | 0.130 |
Why?
|
Hypertrophy | 1 | 2017 | 569 | 0.130 |
Why?
|
Emotions | 3 | 2022 | 2656 | 0.130 |
Why?
|
Algorithms | 10 | 2020 | 13869 | 0.130 |
Why?
|
Cost-Benefit Analysis | 3 | 2018 | 5388 | 0.120 |
Why?
|
Cost Control | 1 | 2017 | 624 | 0.120 |
Why?
|
Cohort Studies | 16 | 2020 | 40545 | 0.120 |
Why?
|
Regression Analysis | 4 | 2023 | 6457 | 0.120 |
Why?
|
Cancer Care Facilities | 4 | 2019 | 402 | 0.120 |
Why?
|
Clinical Competence | 2 | 2023 | 4687 | 0.120 |
Why?
|
Preoperative Care | 4 | 2013 | 2251 | 0.120 |
Why?
|
Hernia, Diaphragmatic | 1 | 1995 | 250 | 0.120 |
Why?
|
Severity of Illness Index | 3 | 2021 | 15526 | 0.120 |
Why?
|
Anastomosis, Surgical | 2 | 2015 | 987 | 0.120 |
Why?
|
Anthropometry | 1 | 2018 | 1348 | 0.120 |
Why?
|
Nose | 1 | 2017 | 509 | 0.120 |
Why?
|
Abdominal Wall | 2 | 2019 | 157 | 0.120 |
Why?
|
Chlorhexidine | 1 | 2015 | 160 | 0.110 |
Why?
|
Developing Countries | 2 | 2024 | 2815 | 0.110 |
Why?
|
SOX Transcription Factors | 1 | 2013 | 8 | 0.110 |
Why?
|
Survival Rate | 6 | 2019 | 12786 | 0.110 |
Why?
|
Digestive System Surgical Procedures | 1 | 2018 | 576 | 0.110 |
Why?
|
Aftercare | 1 | 2019 | 870 | 0.110 |
Why?
|
Neoplasm Staging | 8 | 2017 | 11036 | 0.110 |
Why?
|
British Columbia | 1 | 2013 | 244 | 0.110 |
Why?
|
Forecasting | 2 | 2020 | 2950 | 0.110 |
Why?
|
Selection Bias | 1 | 2015 | 371 | 0.110 |
Why?
|
Epidemiologic Methods | 2 | 2008 | 1364 | 0.110 |
Why?
|
Morbidity | 2 | 2020 | 1768 | 0.110 |
Why?
|
Prosthesis-Related Infections | 2 | 2009 | 537 | 0.110 |
Why?
|
Anti-Infective Agents, Local | 1 | 2015 | 250 | 0.110 |
Why?
|
Coitus | 1 | 2012 | 132 | 0.100 |
Why?
|
Sarcoma | 3 | 2008 | 1898 | 0.100 |
Why?
|
Gastrectomy | 2 | 2020 | 663 | 0.100 |
Why?
|
Fee-for-Service Plans | 1 | 2017 | 694 | 0.100 |
Why?
|
Gastric Bypass | 1 | 2020 | 812 | 0.100 |
Why?
|
Heparin, Low-Molecular-Weight | 2 | 2011 | 339 | 0.100 |
Why?
|
Overweight | 2 | 2022 | 2371 | 0.100 |
Why?
|
Cultural Characteristics | 1 | 2013 | 261 | 0.100 |
Why?
|
Necrosis | 5 | 2018 | 1642 | 0.100 |
Why?
|
Health Care Costs | 2 | 2018 | 3207 | 0.100 |
Why?
|
Sickness Impact Profile | 1 | 2012 | 302 | 0.100 |
Why?
|
Hematoma | 3 | 2012 | 758 | 0.100 |
Why?
|
Temperament | 1 | 2013 | 283 | 0.100 |
Why?
|
Computer Simulation | 3 | 2019 | 6188 | 0.100 |
Why?
|
Treatment Failure | 4 | 2020 | 2617 | 0.100 |
Why?
|
Reimbursement Mechanisms | 1 | 2017 | 670 | 0.100 |
Why?
|
Chi-Square Distribution | 2 | 2016 | 3503 | 0.100 |
Why?
|
Professional-Patient Relations | 1 | 2016 | 737 | 0.100 |
Why?
|
Congresses as Topic | 4 | 2020 | 763 | 0.100 |
Why?
|
Sunscreening Agents | 2 | 2022 | 132 | 0.090 |
Why?
|
Quality Assurance, Health Care | 2 | 2018 | 2211 | 0.090 |
Why?
|
Prostheses and Implants | 1 | 2018 | 1385 | 0.090 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2018 | 991 | 0.090 |
Why?
|
Thoracic Arteries | 1 | 2010 | 41 | 0.090 |
Why?
|
Communication | 4 | 2022 | 3748 | 0.090 |
Why?
|
Self-Assessment | 1 | 2012 | 390 | 0.090 |
Why?
|
Fat Necrosis | 1 | 2010 | 58 | 0.090 |
Why?
|
Physical Fitness | 2 | 2012 | 732 | 0.090 |
Why?
|
Device Removal | 4 | 2021 | 655 | 0.090 |
Why?
|
Students, Medical | 1 | 2023 | 1862 | 0.090 |
Why?
|
Mammary Arteries | 1 | 2010 | 70 | 0.090 |
Why?
|
Travel | 1 | 2016 | 788 | 0.090 |
Why?
|
Risk Factors | 15 | 2020 | 72252 | 0.090 |
Why?
|
Collagen | 3 | 2012 | 2681 | 0.090 |
Why?
|
Neck | 1 | 2014 | 698 | 0.090 |
Why?
|
Carcinoma, Ductal, Breast | 2 | 2020 | 1100 | 0.080 |
Why?
|
Guidelines as Topic | 2 | 2017 | 1404 | 0.080 |
Why?
|
Salvage Therapy | 1 | 2016 | 1275 | 0.080 |
Why?
|
Clinical Trials as Topic | 2 | 2015 | 7908 | 0.080 |
Why?
|
Skull Base Neoplasms | 1 | 2013 | 284 | 0.080 |
Why?
|
Counseling | 3 | 2022 | 1523 | 0.080 |
Why?
|
Exercise | 4 | 2013 | 5611 | 0.080 |
Why?
|
Dermis | 1 | 2010 | 207 | 0.080 |
Why?
|
Attitude of Health Personnel | 2 | 2022 | 3839 | 0.080 |
Why?
|
Poisson Distribution | 3 | 2015 | 513 | 0.080 |
Why?
|
Genital Neoplasms, Female | 1 | 2014 | 523 | 0.080 |
Why?
|
Recovery of Function | 3 | 2017 | 2922 | 0.080 |
Why?
|
Ketorolac | 1 | 2009 | 79 | 0.080 |
Why?
|
Ambulatory Care | 1 | 2019 | 2707 | 0.080 |
Why?
|
Intraoperative Complications | 1 | 2015 | 1195 | 0.080 |
Why?
|
Cutaneous Fistula | 1 | 2008 | 78 | 0.080 |
Why?
|
Laparoscopy | 1 | 2020 | 2148 | 0.080 |
Why?
|
Review Literature as Topic | 1 | 2010 | 336 | 0.080 |
Why?
|
Income | 3 | 2023 | 1913 | 0.080 |
Why?
|
Education, Medical, Continuing | 1 | 2013 | 840 | 0.080 |
Why?
|
Pain Measurement | 4 | 2021 | 3420 | 0.080 |
Why?
|
Software | 2 | 2019 | 4440 | 0.080 |
Why?
|
Expert Testimony | 1 | 2010 | 355 | 0.080 |
Why?
|
Health Services Needs and Demand | 1 | 2016 | 1411 | 0.080 |
Why?
|
Pharyngeal Diseases | 1 | 2008 | 133 | 0.080 |
Why?
|
Feedback | 2 | 2023 | 795 | 0.070 |
Why?
|
Interview, Psychological | 1 | 2010 | 812 | 0.070 |
Why?
|
Funnel Chest | 1 | 2008 | 71 | 0.070 |
Why?
|
Thyroid Neoplasms | 1 | 2020 | 2282 | 0.070 |
Why?
|
Workload | 1 | 2013 | 849 | 0.070 |
Why?
|
Cost of Illness | 1 | 2017 | 1859 | 0.070 |
Why?
|
Pelvic Exenteration | 1 | 2006 | 22 | 0.070 |
Why?
|
Mouth | 1 | 2009 | 374 | 0.070 |
Why?
|
Gene Silencing | 1 | 2013 | 1537 | 0.070 |
Why?
|
Hypopharynx | 1 | 2006 | 52 | 0.070 |
Why?
|
Range of Motion, Articular | 1 | 2013 | 1578 | 0.070 |
Why?
|
Fistula | 1 | 2008 | 221 | 0.070 |
Why?
|
Pulmonary Embolism | 2 | 2010 | 2375 | 0.070 |
Why?
|
Patient Discharge | 1 | 2019 | 3317 | 0.070 |
Why?
|
Disease-Free Survival | 5 | 2016 | 6895 | 0.070 |
Why?
|
Primary Health Care | 1 | 2023 | 4556 | 0.070 |
Why?
|
Pain | 2 | 2023 | 4987 | 0.070 |
Why?
|
Dysphonia | 1 | 2009 | 144 | 0.070 |
Why?
|
Thumb | 1 | 2008 | 227 | 0.070 |
Why?
|
Suction | 1 | 2007 | 267 | 0.070 |
Why?
|
Employment | 2 | 2023 | 1132 | 0.070 |
Why?
|
Skin, Artificial | 1 | 2006 | 90 | 0.070 |
Why?
|
Leg | 1 | 2011 | 1116 | 0.070 |
Why?
|
Skull Neoplasms | 1 | 2006 | 173 | 0.070 |
Why?
|
Omentum | 1 | 2006 | 170 | 0.070 |
Why?
|
Pelvic Floor | 1 | 2006 | 138 | 0.070 |
Why?
|
Body Mass Index | 6 | 2022 | 12718 | 0.070 |
Why?
|
Depression | 4 | 2020 | 7760 | 0.060 |
Why?
|
Activities of Daily Living | 2 | 2012 | 2419 | 0.060 |
Why?
|
Bupivacaine | 1 | 2009 | 411 | 0.060 |
Why?
|
Comprehension | 1 | 2010 | 610 | 0.060 |
Why?
|
Mandible | 1 | 2009 | 718 | 0.060 |
Why?
|
Graft Rejection | 2 | 2016 | 4398 | 0.060 |
Why?
|
Shoulder | 1 | 2007 | 299 | 0.060 |
Why?
|
Thigh | 1 | 2006 | 247 | 0.060 |
Why?
|
Focus Groups | 1 | 2009 | 1320 | 0.060 |
Why?
|
Jejunum | 1 | 2006 | 480 | 0.060 |
Why?
|
Propensity Score | 2 | 2022 | 1781 | 0.060 |
Why?
|
Stockings, Compression | 1 | 2024 | 37 | 0.060 |
Why?
|
Survival Analysis | 5 | 2016 | 10251 | 0.060 |
Why?
|
Uterine Cervical Dysplasia | 1 | 2008 | 387 | 0.060 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2012 | 941 | 0.060 |
Why?
|
Predictive Value of Tests | 4 | 2019 | 15067 | 0.060 |
Why?
|
Trans-Activators | 1 | 2013 | 2927 | 0.060 |
Why?
|
Postoperative Hemorrhage | 1 | 2007 | 409 | 0.060 |
Why?
|
Melanoma | 2 | 2015 | 5508 | 0.060 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2008 | 634 | 0.060 |
Why?
|
Hypopharyngeal Neoplasms | 1 | 2003 | 50 | 0.060 |
Why?
|
Uterine Cervical Neoplasms | 2 | 2008 | 2018 | 0.060 |
Why?
|
Reconstructive Surgical Procedures | 1 | 2002 | 16 | 0.060 |
Why?
|
Chordoma | 1 | 2006 | 359 | 0.050 |
Why?
|
Nuclear Proteins | 1 | 2018 | 5854 | 0.050 |
Why?
|
American Cancer Society | 2 | 2012 | 61 | 0.050 |
Why?
|
Radiography, Panoramic | 1 | 2002 | 113 | 0.050 |
Why?
|
Tumor Suppressor Proteins | 1 | 2013 | 2850 | 0.050 |
Why?
|
Mental Disorders | 1 | 2022 | 6593 | 0.050 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2015 | 2248 | 0.050 |
Why?
|
Information Dissemination | 1 | 2010 | 1099 | 0.050 |
Why?
|
Craniotomy | 1 | 2006 | 729 | 0.050 |
Why?
|
Socioeconomic Factors | 2 | 2013 | 7784 | 0.050 |
Why?
|
Protective Clothing | 1 | 2022 | 102 | 0.050 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2022 | 3921 | 0.050 |
Why?
|
Anesthetics, Local | 1 | 2009 | 985 | 0.050 |
Why?
|
Neurosurgical Procedures | 1 | 2013 | 2002 | 0.050 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 2 | 2009 | 2281 | 0.050 |
Why?
|
Biocompatible Materials | 1 | 2010 | 1731 | 0.050 |
Why?
|
Dextrans | 1 | 2003 | 595 | 0.050 |
Why?
|
Adipose Tissue | 1 | 2013 | 3280 | 0.050 |
Why?
|
Nigeria | 1 | 2024 | 733 | 0.050 |
Why?
|
Electronics | 1 | 2022 | 321 | 0.050 |
Why?
|
Longitudinal Studies | 5 | 2019 | 13980 | 0.050 |
Why?
|
Chemotherapy, Adjuvant | 3 | 2017 | 3480 | 0.050 |
Why?
|
Guideline Adherence | 1 | 2011 | 2265 | 0.050 |
Why?
|
Heparin | 1 | 2008 | 1637 | 0.050 |
Why?
|
Pectoralis Muscles | 1 | 2021 | 82 | 0.050 |
Why?
|
Polymethyl Methacrylate | 2 | 2011 | 145 | 0.050 |
Why?
|
Fees, Pharmaceutical | 1 | 2020 | 64 | 0.050 |
Why?
|
Durapatite | 2 | 2011 | 159 | 0.040 |
Why?
|
Chile | 1 | 2020 | 237 | 0.040 |
Why?
|
New Zealand | 1 | 2020 | 355 | 0.040 |
Why?
|
Double-Blind Method | 2 | 2011 | 12020 | 0.040 |
Why?
|
Health Behavior | 2 | 2022 | 2634 | 0.040 |
Why?
|
Biomedical Technology | 1 | 2022 | 220 | 0.040 |
Why?
|
Polyesters | 2 | 2011 | 362 | 0.040 |
Why?
|
Bone Plates | 1 | 2002 | 468 | 0.040 |
Why?
|
Axilla | 1 | 2021 | 597 | 0.040 |
Why?
|
Wound Healing | 2 | 2008 | 2776 | 0.040 |
Why?
|
Medicare | 1 | 2017 | 6565 | 0.040 |
Why?
|
Child, Preschool | 9 | 2017 | 40964 | 0.040 |
Why?
|
Seroma | 2 | 2010 | 71 | 0.040 |
Why?
|
Thrombosis | 3 | 2008 | 2968 | 0.040 |
Why?
|
Surface Properties | 1 | 2021 | 1168 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 1 | 2020 | 17439 | 0.040 |
Why?
|
Bone Resorption | 1 | 2002 | 722 | 0.040 |
Why?
|
Feeding Behavior | 2 | 2021 | 3187 | 0.040 |
Why?
|
Speech Disorders | 1 | 2019 | 190 | 0.040 |
Why?
|
Publications | 1 | 2020 | 195 | 0.040 |
Why?
|
Microcirculation | 3 | 2008 | 1287 | 0.040 |
Why?
|
Evaluation Studies as Topic | 1 | 2020 | 1677 | 0.040 |
Why?
|
Smoking | 3 | 2014 | 8984 | 0.040 |
Why?
|
Hyaluronic Acid | 2 | 2011 | 491 | 0.040 |
Why?
|
Italy | 1 | 2019 | 829 | 0.040 |
Why?
|
Clinical Clerkship | 1 | 2023 | 532 | 0.040 |
Why?
|
Computers, Handheld | 1 | 2019 | 208 | 0.040 |
Why?
|
Facial Asymmetry | 1 | 2018 | 171 | 0.040 |
Why?
|
Sentinel Lymph Node Biopsy | 1 | 2021 | 710 | 0.040 |
Why?
|
Injury Severity Score | 1 | 2020 | 1014 | 0.040 |
Why?
|
Goals | 1 | 2022 | 708 | 0.040 |
Why?
|
Family Characteristics | 1 | 2021 | 1000 | 0.040 |
Why?
|
North America | 1 | 2020 | 1249 | 0.040 |
Why?
|
Computers | 1 | 2019 | 602 | 0.040 |
Why?
|
Hand Injuries | 1 | 2019 | 242 | 0.030 |
Why?
|
Lactic Acid | 2 | 2011 | 1131 | 0.030 |
Why?
|
Bone Neoplasms | 1 | 2008 | 2529 | 0.030 |
Why?
|
Ductus Arteriosus | 1 | 1995 | 39 | 0.030 |
Why?
|
History, 21st Century | 1 | 2021 | 1532 | 0.030 |
Why?
|
Colorectal Neoplasms | 1 | 2015 | 6773 | 0.030 |
Why?
|
Incidental Findings | 1 | 2020 | 689 | 0.030 |
Why?
|
Thyroidectomy | 1 | 2020 | 879 | 0.030 |
Why?
|
Pancreatic Neoplasms | 1 | 2013 | 5264 | 0.030 |
Why?
|
Persistent Fetal Circulation Syndrome | 1 | 1995 | 80 | 0.030 |
Why?
|
Disability Evaluation | 2 | 2012 | 1828 | 0.030 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2013 | 5230 | 0.030 |
Why?
|
Role | 1 | 2015 | 175 | 0.030 |
Why?
|
Sex Distribution | 1 | 2020 | 2298 | 0.030 |
Why?
|
Photography | 1 | 2017 | 519 | 0.030 |
Why?
|
Sexual Behavior | 2 | 2017 | 2049 | 0.030 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2019 | 717 | 0.030 |
Why?
|
Education, Medical, Undergraduate | 1 | 2023 | 1007 | 0.030 |
Why?
|
Developed Countries | 1 | 2017 | 437 | 0.030 |
Why?
|
Respiratory Distress Syndrome, Newborn | 1 | 1995 | 214 | 0.030 |
Why?
|
New York | 1 | 2016 | 885 | 0.030 |
Why?
|
Polymers | 2 | 2011 | 1621 | 0.030 |
Why?
|
Language | 1 | 2023 | 1468 | 0.030 |
Why?
|
Lymphatic Metastasis | 1 | 2021 | 2924 | 0.030 |
Why?
|
Skin Physiological Phenomena | 1 | 2014 | 180 | 0.030 |
Why?
|
Abdomen | 1 | 2019 | 1117 | 0.030 |
Why?
|
Compression Bandages | 1 | 2013 | 15 | 0.030 |
Why?
|
History, 20th Century | 1 | 2021 | 2736 | 0.030 |
Why?
|
Geography | 1 | 2016 | 669 | 0.030 |
Why?
|
Cranial Fossa, Middle | 1 | 2013 | 28 | 0.030 |
Why?
|
Rectal Neoplasms | 1 | 2002 | 1205 | 0.030 |
Why?
|
Brain Neoplasms | 1 | 2014 | 8856 | 0.030 |
Why?
|
Vascular Patency | 1 | 2015 | 887 | 0.030 |
Why?
|
Electronic Health Records | 2 | 2022 | 4467 | 0.030 |
Why?
|
Age Distribution | 1 | 2018 | 2899 | 0.030 |
Why?
|
Chromosomes, Human, Pair 6 | 1 | 2013 | 380 | 0.030 |
Why?
|
Analgesia, Patient-Controlled | 1 | 2012 | 109 | 0.030 |
Why?
|
Rural Population | 1 | 2022 | 2207 | 0.030 |
Why?
|
Hospital Charges | 1 | 2014 | 362 | 0.030 |
Why?
|
Fellowships and Scholarships | 1 | 2020 | 1077 | 0.030 |
Why?
|
Abdominal Fat | 1 | 2013 | 223 | 0.030 |
Why?
|
Neoplasm, Residual | 1 | 2016 | 973 | 0.020 |
Why?
|
Prevalence | 2 | 2019 | 15211 | 0.020 |
Why?
|
Europe | 1 | 2018 | 3336 | 0.020 |
Why?
|
Health Care Surveys | 1 | 2018 | 2453 | 0.020 |
Why?
|
Academic Medical Centers | 1 | 2021 | 2760 | 0.020 |
Why?
|
Prostatic Neoplasms | 1 | 2013 | 11059 | 0.020 |
Why?
|
Suture Techniques | 1 | 2015 | 797 | 0.020 |
Why?
|
Narcotics | 1 | 2012 | 343 | 0.020 |
Why?
|
Caregivers | 1 | 2022 | 2098 | 0.020 |
Why?
|
Ultrasonography, Doppler, Duplex | 1 | 2011 | 205 | 0.020 |
Why?
|
Injections, Subcutaneous | 1 | 2011 | 667 | 0.020 |
Why?
|
Health Expenditures | 1 | 2023 | 2348 | 0.020 |
Why?
|
Lymph Nodes | 1 | 2021 | 3476 | 0.020 |
Why?
|
Skull Base | 1 | 2013 | 305 | 0.020 |
Why?
|
Policy Making | 1 | 2013 | 554 | 0.020 |
Why?
|
Beauty | 1 | 2009 | 42 | 0.020 |
Why?
|
Quality-Adjusted Life Years | 1 | 2016 | 1683 | 0.020 |
Why?
|
Skin Diseases | 1 | 2018 | 1066 | 0.020 |
Why?
|
DNA Methylation | 2 | 2013 | 4286 | 0.020 |
Why?
|
Drainage | 1 | 2015 | 1142 | 0.020 |
Why?
|
Lung Neoplasms | 1 | 2013 | 13112 | 0.020 |
Why?
|
Social Support | 1 | 2018 | 2118 | 0.020 |
Why?
|
Genes, Tumor Suppressor | 1 | 2013 | 1097 | 0.020 |
Why?
|
Single-Blind Method | 1 | 2012 | 1586 | 0.020 |
Why?
|
Models, Organizational | 1 | 2012 | 574 | 0.020 |
Why?
|
Science | 1 | 2011 | 239 | 0.020 |
Why?
|
Deglutition | 1 | 2009 | 198 | 0.020 |
Why?
|
Mobility Limitation | 1 | 2012 | 409 | 0.020 |
Why?
|
Muscle Strength | 1 | 2012 | 592 | 0.020 |
Why?
|
Program Development | 1 | 2014 | 1314 | 0.020 |
Why?
|
Mutation | 3 | 2020 | 29777 | 0.020 |
Why?
|
Adverse Drug Reaction Reporting Systems | 1 | 2011 | 469 | 0.020 |
Why?
|
Expressed Sequence Tags | 1 | 2008 | 255 | 0.020 |
Why?
|
Therapeutic Irrigation | 1 | 2009 | 300 | 0.020 |
Why?
|
Mice, SCID | 1 | 2013 | 2718 | 0.020 |
Why?
|
Bibliometrics | 1 | 2011 | 338 | 0.020 |
Why?
|
Palliative Care | 1 | 2022 | 3490 | 0.020 |
Why?
|
Fibula | 1 | 2009 | 268 | 0.020 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2013 | 8430 | 0.020 |
Why?
|
Intubation, Intratracheal | 1 | 1995 | 1365 | 0.020 |
Why?
|
Intraoperative Period | 1 | 2008 | 520 | 0.020 |
Why?
|
Early Diagnosis | 1 | 2012 | 1186 | 0.020 |
Why?
|
Tumor Burden | 1 | 2013 | 1917 | 0.020 |
Why?
|
Data Interpretation, Statistical | 1 | 2017 | 2715 | 0.020 |
Why?
|
Laryngectomy | 1 | 2008 | 248 | 0.020 |
Why?
|
Gene Frequency | 1 | 2013 | 3585 | 0.020 |
Why?
|
Sacrococcygeal Region | 1 | 2006 | 52 | 0.020 |
Why?
|
Women's Health | 1 | 2016 | 2033 | 0.020 |
Why?
|
Health Surveys | 1 | 2016 | 4036 | 0.020 |
Why?
|
Patient Readmission | 1 | 2020 | 3117 | 0.020 |
Why?
|
Clinical Protocols | 1 | 2012 | 1459 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2011 | 2883 | 0.020 |
Why?
|
Comorbidity | 1 | 2020 | 10380 | 0.020 |
Why?
|
Radiation Injuries | 1 | 2013 | 1180 | 0.020 |
Why?
|
Patient Protection and Affordable Care Act | 1 | 2016 | 1209 | 0.020 |
Why?
|
Gene Deletion | 1 | 2013 | 2749 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 2013 | 6311 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 4749 | 0.020 |
Why?
|
Soft Tissue Injuries | 1 | 2007 | 176 | 0.020 |
Why?
|
Gene Library | 1 | 2008 | 1074 | 0.020 |
Why?
|
Blotting, Western | 1 | 2013 | 5179 | 0.020 |
Why?
|
Radiography | 2 | 2008 | 7010 | 0.020 |
Why?
|
Laryngeal Neoplasms | 1 | 2008 | 512 | 0.020 |
Why?
|
Cause of Death | 1 | 1995 | 3580 | 0.020 |
Why?
|
Adenocarcinoma | 1 | 2002 | 6363 | 0.020 |
Why?
|
Speech | 1 | 2009 | 541 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 1 | 2008 | 20121 | 0.020 |
Why?
|
Transplantation, Heterologous | 1 | 2013 | 2378 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2013 | 21733 | 0.020 |
Why?
|
Extracorporeal Membrane Oxygenation | 1 | 1995 | 1354 | 0.020 |
Why?
|
Insurance Coverage | 1 | 2016 | 1900 | 0.020 |
Why?
|
Respiration, Artificial | 1 | 1995 | 2568 | 0.020 |
Why?
|
DNA Copy Number Variations | 1 | 2013 | 1937 | 0.020 |
Why?
|
Mouth Neoplasms | 1 | 2009 | 601 | 0.010 |
Why?
|
Primary Prevention | 1 | 2011 | 1167 | 0.010 |
Why?
|
Genetic Association Studies | 1 | 2013 | 2703 | 0.010 |
Why?
|
Oxygen | 1 | 1995 | 4189 | 0.010 |
Why?
|
Aspirin | 2 | 2007 | 3283 | 0.010 |
Why?
|
HEK293 Cells | 1 | 2013 | 4204 | 0.010 |
Why?
|
Infant, Newborn | 2 | 2011 | 25609 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2011 | 4931 | 0.010 |
Why?
|
Tissue Survival | 1 | 2003 | 118 | 0.010 |
Why?
|
Cell Survival | 1 | 2013 | 5881 | 0.010 |
Why?
|
Sex Factors | 1 | 2016 | 10394 | 0.010 |
Why?
|
DNA, Neoplasm | 1 | 2008 | 1758 | 0.010 |
Why?
|
Research | 1 | 2011 | 1999 | 0.010 |
Why?
|
Costs and Cost Analysis | 1 | 2008 | 1680 | 0.010 |
Why?
|
Stomach Neoplasms | 1 | 2011 | 1332 | 0.010 |
Why?
|
Molecular Weight | 1 | 2003 | 2253 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2008 | 35409 | 0.010 |
Why?
|
Epigenesis, Genetic | 1 | 2013 | 3645 | 0.010 |
Why?
|
Genome, Human | 1 | 2013 | 4418 | 0.010 |
Why?
|
Quebec | 1 | 2000 | 134 | 0.010 |
Why?
|
United States Food and Drug Administration | 1 | 2008 | 1582 | 0.010 |
Why?
|
Maryland | 1 | 2000 | 276 | 0.010 |
Why?
|
Ischemia | 1 | 2008 | 1907 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2011 | 10940 | 0.010 |
Why?
|
Radiotherapy Dosage | 1 | 2005 | 2879 | 0.010 |
Why?
|
Monitoring, Physiologic | 1 | 2006 | 1738 | 0.010 |
Why?
|
Up-Regulation | 1 | 2008 | 4221 | 0.010 |
Why?
|
Health Services Accessibility | 1 | 2016 | 5136 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2008 | 6170 | 0.010 |
Why?
|
Genetic Variation | 1 | 2013 | 6535 | 0.010 |
Why?
|
Infant | 2 | 2011 | 35122 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2013 | 19232 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2013 | 16674 | 0.010 |
Why?
|
Biopsy | 1 | 2008 | 6750 | 0.010 |
Why?
|
Diabetes Mellitus | 1 | 2014 | 5752 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2013 | 15518 | 0.010 |
Why?
|
Genomics | 1 | 2008 | 5714 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2012 | 13691 | 0.010 |
Why?
|
Referral and Consultation | 1 | 2000 | 3530 | 0.000 |
Why?
|
Animals | 1 | 2013 | 168660 | 0.000 |
Why?
|